Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 106


Protective Immunity and New Vaccines for Lyme Disease.

Gomes-Solecki M, Arnaboldi PM, Backenson PB, Benach JL, Cooper CL, Dattwyler RJ, Diuk-Wasser M, Fikrig E, Hovius JW, Laegreid W, Lundberg U, Marconi RT, Marques AR, Molloy P, Narasimhan S, Pal U, Pedra JHF, Plotkin S, Rock DL, Rosa P, Telford SR, Tsao J, Yang XF, Schutzer SE.

Clin Infect Dis. 2019 Oct 17. pii: ciz872. doi: 10.1093/cid/ciz872. [Epub ahead of print]


Linear B Cell Epitopes Derived from the Multifunctional Surface Lipoprotein BBK32 as Targets for the Serodiagnosis of Lyme Disease.

Toumanios C, Prisco L, Dattwyler RJ, Arnaboldi PM.

mSphere. 2019 May 1;4(3). pii: e00111-19. doi: 10.1128/mSphere.00111-19.


Direct Diagnostic Tests for Lyme Disease.

Schutzer SE, Body BA, Boyle J, Branson BM, Dattwyler RJ, Fikrig E, Gerald NJ, Gomes-Solecki M, Kintrup M, Ledizet M, Levin AE, Lewinski M, Liotta LA, Marques A, Mead PS, Mongodin EF, Pillai S, Rao P, Robinson WH, Roth KM, Schriefer ME, Slezak T, Snyder JL, Steere AC, Witkowski J, Wong SJ, Branda JA.

Clin Infect Dis. 2019 Mar 5;68(6):1052-1057. doi: 10.1093/cid/ciy614.


Advances in Serodiagnostic Testing for Lyme Disease Are at Hand.

Branda JA, Body BA, Boyle J, Branson BM, Dattwyler RJ, Fikrig E, Gerald NJ, Gomes-Solecki M, Kintrup M, Ledizet M, Levin AE, Lewinski M, Liotta LA, Marques A, Mead PS, Mongodin EF, Pillai S, Rao P, Robinson WH, Roth KM, Schriefer ME, Slezak T, Snyder J, Steere AC, Witkowski J, Wong SJ, Schutzer SE.

Clin Infect Dis. 2018 Mar 19;66(7):1133-1139. doi: 10.1093/cid/cix943.


Elimination of Babesia microti Is Dependent on Intraerythrocytic Killing and CD4+ T Cells.

Skariah S, Arnaboldi P, Dattwyler RJ, Sultan AA, Gaylets C, Walwyn O, Mulhall H, Wu X, Dargham SR, Mordue DG.

J Immunol. 2017 Jul 15;199(2):633-642. doi: 10.4049/jimmunol.1601193. Epub 2017 Jun 12.


Borrelia burgdorferi-specific IgA in Lyme Disease.

D'Arco C, Dattwyler RJ, Arnaboldi PM.

EBioMedicine. 2017 May;19:91-97. doi: 10.1016/j.ebiom.2017.04.025. Epub 2017 Apr 21.


Response letter to Drs. Halperin and Greenberg.

Wormser GP, Strle F, Shapiro ED, Dattwyler RJ, Auwaerter PG.

Diagn Microbiol Infect Dis. 2017 May;88(1):108-109. doi: 10.1016/j.diagmicrobio.2017.01.018. Epub 2017 Feb 8. No abstract available.


A critical appraisal of the mild axonal peripheral neuropathy of late neurologic Lyme disease.

Wormser GP, Strle F, Shapiro ED, Dattwyler RJ, Auwaerter PG.

Diagn Microbiol Infect Dis. 2017 Feb;87(2):163-167. doi: 10.1016/j.diagmicrobio.2016.11.003. Epub 2016 Nov 12. Review.


Intranasal delivery of a protein subunit vaccine using a Tobacco Mosaic Virus platform protects against pneumonic plague.

Arnaboldi PM, Sambir M, D'Arco C, Peters LA, Seegers JF, Mayer L, McCormick AA, Dattwyler RJ.

Vaccine. 2016 Nov 11;34(47):5768-5776. doi: 10.1016/j.vaccine.2016.09.063. Epub 2016 Oct 13.


Detection of IFN-γ Secretion by T Cells Collected Before and After Successful Treatment of Early Lyme Disease.

Callister SM, Jobe DA, Stuparic-Stancic A, Miyamasu M, Boyle J, Dattwyler RJ, Arnaboldi PM.

Clin Infect Dis. 2016 May 15;62(10):1235-1241. doi: 10.1093/cid/ciw112. Epub 2016 Mar 1.


Development of a Multiantigen Panel for Improved Detection of Borrelia burgdorferi Infection in Early Lyme Disease.

Lahey LJ, Panas MW, Mao R, Delanoy M, Flanagan JJ, Binder SR, Rebman AW, Montoya JG, Soloski MJ, Steere AC, Dattwyler RJ, Arnaboldi PM, Aucott JN, Robinson WH.

J Clin Microbiol. 2015 Dec;53(12):3834-41. doi: 10.1128/JCM.02111-15. Epub 2015 Oct 7.


Cross-Reactive Epitopes in Borrelia burgdorferi p66.

Arnaboldi PM, Dattwyler RJ.

Clin Vaccine Immunol. 2015 Jul;22(7):840-3. doi: 10.1128/CVI.00217-15. Epub 2015 May 13.


Comparison of lyme disease serologic assays and lyme specialty laboratories.

Dattwyler RJ, Arnaboldi PM.

Clin Infect Dis. 2014 Dec 15;59(12):1711-3. doi: 10.1093/cid/ciu705. Epub 2014 Sep 2. No abstract available.


Decorin binding proteins A and B in the serodiagnosis of Lyme disease in North America.

Arnaboldi PM, Sambir M, Dattwyler RJ.

Clin Vaccine Immunol. 2014 Oct;21(10):1426-36. doi: 10.1128/CVI.00383-14. Epub 2014 Aug 13.


Identification of OppA2 linear epitopes as serodiagnostic markers for Lyme disease.

Signorino G, Arnaboldi PM, Petzke MM, Dattwyler RJ.

Clin Vaccine Immunol. 2014 May;21(5):704-11. doi: 10.1128/CVI.00792-13. Epub 2014 Mar 12.


The reply.

Klempner MS, Baker PJ, Shapiro ED, Marques A, Dattwyler RJ, Halperin JJ, Wormser GP.

Am J Med. 2014 Feb;127(2):e11-2. doi: 10.1016/j.amjmed.2013.09.029. Epub 2013 Oct 15. No abstract available.


Treatment trials for post-Lyme disease symptoms revisited.

Klempner MS, Baker PJ, Shapiro ED, Marques A, Dattwyler RJ, Halperin JJ, Wormser GP.

Am J Med. 2013 Aug;126(8):665-9. doi: 10.1016/j.amjmed.2013.02.014. Epub 2013 Jun 10. Review.


Outer surface protein C peptide derived from Borrelia burgdorferi sensu stricto as a target for serodiagnosis of early lyme disease.

Arnaboldi PM, Seedarnee R, Sambir M, Callister SM, Imparato JA, Dattwyler RJ.

Clin Vaccine Immunol. 2013 Apr;20(4):474-81. doi: 10.1128/CVI.00608-12. Epub 2013 Jan 30.


Antiscience and ethical concerns associated with advocacy of Lyme disease.

Auwaerter PG, Bakken JS, Dattwyler RJ, Dumler JS, Halperin JJ, McSweegan E, Nadelman RB, O'Connell S, Shapiro ED, Sood SK, Steere AC, Weinstein A, Wormser GP.

Lancet Infect Dis. 2011 Sep;11(9):713-9. doi: 10.1016/S1473-3099(11)70034-2.


Scientific evidence and best patient care practices should guide the ethics of Lyme disease activism.

Auwaerter PG, Bakken JS, Dattwyler RJ, Dumler JS, Halperin JJ, McSweegan E, Nadelman RB, O'Connell S, Sood SK, Weinstein A, Wormser GP.

J Med Ethics. 2011 Feb;37(2):68-73. doi: 10.1136/jme.2009.032896. Epub 2010 Nov 21.


Platform technology to deliver prophylactic molecules orally: an example using the Class A select agent Yersinia pestis.

del Rio B, Fuente JL, Neves V, Dattwyler R, Seegers JF, Gomes-Solecki M.

Vaccine. 2010 Sep 24;28(41):6714-22. doi: 10.1016/j.vaccine.2010.07.084. Epub 2010 Aug 8.


A commentary on the treatment of early lyme disease.

Dattwyler RJ.

Clin Infect Dis. 2010 Feb 15;50(4):521-2. doi: 10.1086/649921. No abstract available.


Analysis of a flawed double-blind, placebo-controlled, clinical trial of patients claimed to have persistent Lyme disease following treatment.

Wormser GP, Shapiro ED, Halperin JJ, Porwancher RB, O'Connell S, Nadelman RB, Strle F, Radolf JD, Hovius JW, Baker PJ, Fingerle V, Dattwyler R.

Minerva Med. 2009 Apr;100(2):171-2. No abstract available.


Oral immunization with recombinant lactobacillus plantarum induces a protective immune response in mice with Lyme disease.

del Rio B, Dattwyler RJ, Aroso M, Neves V, Meirelles L, Seegers JF, Gomes-Solecki M.

Clin Vaccine Immunol. 2008 Sep;15(9):1429-35. doi: 10.1128/CVI.00169-08. Epub 2008 Jul 16.


Anti-tumor necrosis factor-alpha activation of Borrelia burgdorferi spirochetes in antibiotic-treated murine Lyme borreliosis: an unproven conclusion.

Wormser GP, Barthold SW, Shapiro ED, Dattwyler RJ, Bakken JS, Steere AC, Bockenstedt LK, Radolf JD.

J Infect Dis. 2007 Dec 15;196(12):1865-6; author reply 1866-7. doi: 10.1086/523826. No abstract available.


A critical appraisal of "chronic Lyme disease".

Feder HM Jr, Johnson BJ, O'Connell S, Shapiro ED, Steere AC, Wormser GP; Ad Hoc International Lyme Disease Group, Agger WA, Artsob H, Auwaerter P, Dumler JS, Bakken JS, Bockenstedt LK, Green J, Dattwyler RJ, Munoz J, Nadelman RB, Schwartz I, Draper T, McSweegan E, Halperin JJ, Klempner MS, Krause PJ, Mead P, Morshed M, Porwancher R, Radolf JD, Smith RP Jr, Sood S, Weinstein A, Wong SJ, Zemel L.

N Engl J Med. 2007 Oct 4;357(14):1422-30. Review. No abstract available. Erratum in: N Engl J Med. 2008 Mar 6;358(10):1084. Agger, WA [added]; Artsob, H [added]; Auwaerter, P [added]; Dumler, JS [added]; Bakken, JS [added]; Bockenstedt, LK [added]; Green, J [added]; Dattwyler, RJ [added]; Munoz, J [added]; Nadelman, RB [added]; Schwartz, I [added]; Draper, T [added]; McSweegan,.


Epitope length, genospecies dependency, and serum panel effect in the IR6 enzyme-linked immunosorbent assay for detection of antibodies to Borrelia burgdorferi.

Gomes-Solecki MJ, Meirelles L, Glass J, Dattwyler RJ.

Clin Vaccine Immunol. 2007 Jul;14(7):875-9. Epub 2007 May 30.


Single-dose prophylaxis against Lyme disease.

Wormser GP, Dattwyler RJ, Shapiro ED, Dumler JS, O'Connell S, Radolf JD, Nadelman RB.

Lancet Infect Dis. 2007 Jun;7(6):371-3. No abstract available.


The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America.

Wormser GP, Dattwyler RJ, Shapiro ED, Halperin JJ, Steere AC, Klempner MS, Krause PJ, Bakken JS, Strle F, Stanek G, Bockenstedt L, Fish D, Dumler JS, Nadelman RB.

Clin Infect Dis. 2006 Nov 1;43(9):1089-134. Epub 2006 Oct 2. Erratum in: Clin Infect Dis. 2007 Oct 1;45(7):941.


Response to meta-analysis of Lyme borreliosis symptoms.

Shapiro ED, Dattwyler R, Nadelman RB, Wormser GP.

Int J Epidemiol. 2005 Dec;34(6):1437-9; author reply 1440-3. Epub 2005 Nov 30. No abstract available.


Oral vaccine that breaks the transmission cycle of the Lyme disease spirochete can be delivered via bait.

Gomes-Solecki MJ, Brisson DR, Dattwyler RJ.

Vaccine. 2006 May 15;24(20):4440-9. Epub 2005 Sep 12.


Community-acquired pneumonia in the age of bio-terrorism.

Dattwyler RJ.

Allergy Asthma Proc. 2005 May-Jun;26(3):191-4. Review.


A comparison of two treatment regimens of ceftriaxone in late Lyme disease.

Dattwyler RJ, Wormser GP, Rush TJ, Finkel MF, Schoen RT, Grunwaldt E, Franklin M, Hilton E, Bryant GL, Agger WA, Maladorno D.

Wien Klin Wochenschr. 2005 Jun;117(11-12):393-7.


LcrV capture enzyme-linked immunosorbent assay for detection of Yersinia pestis from human samples.

Gomes-Solecki MJ, Savitt AG, Rowehl R, Glass JD, Bliska JB, Dattwyler RJ.

Clin Diagn Lab Immunol. 2005 Feb;12(2):339-46.


IgE antithyroid antibodies in patients with Hashimoto's disease and chronic urticaria.

Concha LB, Chang CC, Szema AM, Dattwyler RJ, Carlson HE.

Allergy Asthma Proc. 2004 Sep-Oct;25(5):293-6.


Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial.

Krupp LB, Hyman LG, Grimson R, Coyle PK, Melville P, Ahnn S, Dattwyler R, Chandler B.

Neurology. 2003 Jun 24;60(12):1923-30.


IFNgamma production in peripheral blood of early Lyme disease patients to hLFAalphaL (aa326-345).

Gomes-Solecki MJ, Wormser GP, Dattwyler RJ.

BMC Musculoskelet Disord. 2002 Oct 17;3:25.


Single-dose doxycycline for the prevention of Lyme disease.

Pontrelli L, Dattwyler R, Nachman S.

N Engl J Med. 2001 Nov 1;345(18):1348; author reply 1349-50. No abstract available.


Recombinant assay for serodiagnosis of Lyme disease regardless of OspA vaccination status.

Gomes-Solecki MJ, Wormser GP, Schriefer M, Neuman G, Hannafey L, Glass JD, Dattwyler RJ.

J Clin Microbiol. 2002 Jan;40(1):193-7.


A first-tier rapid assay for the serodiagnosis of Borrelia burgdorferi infection.

Gomes-Solecki MJ, Wormser GP, Persing DH, Berger BW, Glass JD, Yang X, Dattwyler RJ.

Arch Intern Med. 2001 Sep 10;161(16):2015-20.


Practice guidelines for the treatment of Lyme disease. The Infectious Diseases Society of America.

Wormser GP, Nadelman RB, Dattwyler RJ, Dennis DT, Shapiro ED, Steere AC, Rush TJ, Rahn DW, Coyle PK, Persing DH, Fish D, Luft BJ.

Clin Infect Dis. 2000 Jul;31 Suppl 1:1-14. No abstract available.


Recombinant chimeric Borrelia proteins for diagnosis of Lyme disease.

Gomes-Solecki MJ, Dunn JJ, Luft BJ, Castillo J, Dykhuizen DE, Yang X, Glass JD, Dattwyler RJ.

J Clin Microbiol. 2000 Jul;38(7):2530-5.


Infection with multiple strains of Borrelia burgdorferi sensu stricto in patients with Lyme disease.

Seinost G, Golde WT, Berger BW, Dunn JJ, Qiu D, Dunkin DS, Dykhuizen DE, Luft BJ, Dattwyler RJ.

Arch Dermatol. 1999 Nov;135(11):1329-33.


A rapid test for detection of Lyme disease antibodies.

Dattwyler RJ, Gomes-Solecki M.

Am Clin Lab. 1999 Jul;18(6):6. No abstract available.


Four clones of Borrelia burgdorferi sensu stricto cause invasive infection in humans.

Seinost G, Dykhuizen DE, Dattwyler RJ, Golde WT, Dunn JJ, Wang IN, Wormser GP, Schriefer ME, Luft BJ.

Infect Immun. 1999 Jul;67(7):3518-24.


[Cardiac manifestations of Lyme borreliosis with special reference to contractile dysfunction].

Seinost G, Gasser R, Reisinger E, Rigler MY, Fischer L, Keplinger A, Dattwyler RJ, Dunn JJ, Klein W.

Acta Med Austriaca. 1998;25(2):44-50. German.


Simultaneous expression of Borrelia OspA and OspC and IgM response in cerebrospinal fluid in early neurologic Lyme disease.

Schutzer SE, Coyle PK, Krupp LB, Deng Z, Belman AL, Dattwyler R, Luft BJ.

J Clin Invest. 1997 Aug 15;100(4):763-7.


Ceftriaxone compared with doxycycline for the treatment of acute disseminated Lyme disease.

Dattwyler RJ, Luft BJ, Kunkel MJ, Finkel MF, Wormser GP, Rush TJ, Grunwaldt E, Agger WA, Franklin M, Oswald D, Cockey L, Maladorno D.

N Engl J Med. 1997 Jul 31;337(5):289-94.


Azithromycin compared with amoxicillin in the treatment of erythema migrans. A double-blind, randomized, controlled trial.

Luft BJ, Dattwyler RJ, Johnson RC, Luger SW, Bosler EM, Rahn DW, Masters EJ, Grunwaldt E, Gadgil SD.

Ann Intern Med. 1996 May 1;124(9):785-91.


Improved serodiagnostic testing for Lyme disease: results of a multicenter serologic evaluation.

Craven RB, Quan TJ, Bailey RE, Dattwyler R, Ryan RW, Sigal LH, Steere AC, Sullivan B, Johnson BJ, Dennis DT, Gubler DJ.

Emerg Infect Dis. 1996 Apr-Jun;2(2):136-40. No abstract available.

Supplemental Content

Loading ...
Support Center